BiondVax to Present on September 10 at the Rodman & Renshaw Global Investment Conference

Press Release
Written By

Ness Ziona, Israel – September 8, 2015 – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) today announced today that the Company’s CEO, Dr. Ron Babecoff, will participate in the Rodman & Renshaw 17th Annual Global Investment Conference, taking place at the St. Regis hotel in New York from September 8-10, 2015.BiondVax CEO, Dr. Ron Babecoff, is scheduled to present on Thursday, September 10, 2015 at 10:25am Eastern Time.  The corporate presentation which Dr. Babecoff will present at the conference is available for download from the investor relations section of BiondVax’s website.At the conference there will be an opportunity for investors to meet one-on-one with Dr. Ron Babecoff. In addition, Dr. Babecoff will be meeting investors and analysts throughout the week on a non-deal roadshow in both Boston and New York. Investors interested in meeting with management should contact the Investor Relations team at BiondVax. 

Previous

BiondVax Initiates a Phase IIb Clinical Trial in Europe for its Universal Flu Vaccine for Pandemic Outbreak
Next

BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health